876-877 / 1173
ESTRO
Use of FDG-PET for target volume delineation in 3D-
CRT/IMRT for head and neck tumors
To evaluate the feasibility and safety of the use of FDG-PET
for primary tumor GTV delineation in locally advanced H&N
SCC patients treated by 3D-CRT and IMRT in a multicentric
setting
Primary objective of the study
Cliniques universitaires St-Luc, Brussels, Belgium
Centre OscartLambret, Lille, France
Cliniques St-Elisabeth, Namur, Belgium